CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 139 enrolled
Drug / intervention
Trace elements replacementother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03204669
NCT03204669N/ACompleted

Trace Element Repletion Following Severe Burn Injury

Centre Hospitalier Universitaire Vaudois·observational·Posted Jul 2, 2017·Updated Jul 2, 2017

In Brief

An observational study evaluating Trace elements replacement for Critical Illness and 3 related conditions. Completed, enrolled 139 participants across 1 site.

Detailed Summary

Major burn patients are characterized by large exudative losses of Cu, Se and Zn. Trace element (TE) repletion has been shown to improve clinical outcome. The study aimed to check if our repletion protocols were achieving normalization of TE plasma concentrations of major burn patients and if the necessity for continuous renal replacement therapy (CRRT) might increase the needs.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2, 2017
Enrollment StartJun 1, 1999
Primary CompletionDec 31, 2015
TodayJul 2, 2026
Enrollment to primary: 16.6 yearsPosted 9 years ago

Interventions

Trace elements replacementother